Granite Point Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-50,000
Closed -$686K 103
2017
Q1
$686K Buy
+50,000
New +$686K 0.21% 50